1,078 results found

When little robots burst on to our screens to the tune of the "Hamburger Rhumba" in the (some would say) "classic" hit 1987 film, "Batteries Not Included", the idea of robots...

A recipe for growth: House of Commons select committee issues recommendations for preserving the UK processed food and drink sector

In this blog post, experts from across our pharma regulatory, IP and competition teams provide a brief snapshot of some of the key European developments which companies in the pharma sector should be aware of.

Following the political agreement between the European Commission, the European Council, and European Parliament in December 2022, the European Council formally adopted the EU Deforestation...

BCL partner John Binns and associate David Hardstaff's article ‘Medical cannabis law has been left in a haze' has been published by The Times.

BCL partner John Binns and associate David Hardstaff ask if a new report should put a spring in the step of UK businesses with an interest in medicinal cannabis and cannabidiol (CBD)...

Early last month, reports said US-based Scottish scientist Dr Kate Broderick was actively developing a vaccine against Covid-19 and the speed of development was "unprecedented".

You're a developer who has to comply with the biodiversity net gain (BNG) requirement.

The Department of Justice (DOJ) recently intervened in a False Claims Act (FCA) lawsuit involving allegations of kickbacks for prescription drug copays. The DOJ says

Our first keynote at xCHANGE 2025 was a session led by Dominic Sandbrook, historian, author and co-host of the hugely popular podcast "The Rest is History".

Mr. Wood worked for the Durham County Council as a Behavioural Officer.

Developing new or more effective drugs for treating medical conditions can revolutionise care, and drug discovery is a huge part of the business of pharmaceutical companies.

Last month, CMS updated Chapters 13 and 14 from the Part D Prescription Drug Benefit Manual (PDBM).

A recent ruling of the European Court of Justice (Judgment in Case C-544/10 Deutsches Weintor eG v Land Rheinland-Pfalz) examined issues surrounding what constituted a health claim for a product under Health & Nutrition Claims Regulation 1924/2006 (NHCR).

On 16 January, EFSA published its report concerning the impact of neonicotinoids on honey bees.

In due course, non-UK businesses will need to consider putting in place arrangements with a UK based importer or setting up a UK business to fulfil this function.

The programme aims to accelerate market access for innovative food products while maintaining robust safety standards.